139 related articles for article (PubMed ID: 9507023)
21. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
Rui L; Mathews LS; Hotta K; Gustafson TA; Carter-Su C
Mol Cell Biol; 1997 Nov; 17(11):6633-44. PubMed ID: 9343427
[TBL] [Abstract][Full Text] [Related]
22. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
[TBL] [Abstract][Full Text] [Related]
24. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
[TBL] [Abstract][Full Text] [Related]
26. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of leukemia inhibitory factor-stimulated neuronal gene expression by protein phosphatases SHP-1 and SHP-2 through mitogen-activated protein kinase-dependent and -independent pathways.
Bartoe JL; Nathanson NM
J Neurochem; 2000 May; 74(5):2021-32. PubMed ID: 10800945
[TBL] [Abstract][Full Text] [Related]
28. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins.
Hackett RH; Wang YD; Sweitzer S; Feldman G; Wood WI; Larner AC
J Biol Chem; 1997 Apr; 272(17):11128-32. PubMed ID: 9111009
[TBL] [Abstract][Full Text] [Related]
29. Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation.
Eminaga S; Bennett AM
J Biol Chem; 2008 May; 283(22):15328-38. PubMed ID: 18378677
[TBL] [Abstract][Full Text] [Related]
30. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
31. SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis.
Kontaridis MI; Liu X; Zhang L; Bennett AM
J Cell Sci; 2001 Jun; 114(Pt 11):2187-98. PubMed ID: 11493654
[TBL] [Abstract][Full Text] [Related]
32. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
Carter-Su C; Rui L; Stofega MR
Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
[TBL] [Abstract][Full Text] [Related]
33. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation.
Blanchette J; Racette N; Faure R; Siminovitch KA; Olivier M
Eur J Immunol; 1999 Nov; 29(11):3737-44. PubMed ID: 10556830
[TBL] [Abstract][Full Text] [Related]
34. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
[TBL] [Abstract][Full Text] [Related]
35. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
36. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
Rui L; Gunter DR; Herrington J; Carter-Su C
Mol Cell Biol; 2000 May; 20(9):3168-77. PubMed ID: 10757801
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.
Gu F; Dubé N; Kim JW; Cheng A; Ibarra-Sanchez Mde J; Tremblay ML; Boisclair YR
Mol Cell Biol; 2003 Jun; 23(11):3753-62. PubMed ID: 12748279
[TBL] [Abstract][Full Text] [Related]
38. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone.
Campbell GS; Christian LJ; Carter-Su C
J Biol Chem; 1993 Apr; 268(10):7427-34. PubMed ID: 8385106
[TBL] [Abstract][Full Text] [Related]
39. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor.
Kimura T; Zhang J; Sagawa K; Sakaguchi K; Appella E; Siraganian RP
J Immunol; 1997 Nov; 159(9):4426-34. PubMed ID: 9379041
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling.
Argetsinger LS; Norstedt G; Billestrup N; White MF; Carter-Su C
J Biol Chem; 1996 Nov; 271(46):29415-21. PubMed ID: 8910607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
